RESUMEN
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.
Asunto(s)
Bacteriemia/diagnóstico , Bacteriemia/patología , Fibrosis Quística/complicaciones , Ochrobactrum anthropi/aislamiento & purificación , Adulto , Antibacterianos/farmacología , Bacteriemia/microbiología , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Pruebas de Sensibilidad Microbiana , Ochrobactrum anthropi/clasificación , Ochrobactrum anthropi/efectos de los fármacos , Ochrobactrum anthropi/genéticaRESUMEN
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.
Asunto(s)
Adulto , Femenino , Humanos , Recién Nacido , Bacteriemia/diagnóstico , Bacteriemia/patología , Fibrosis Quística/complicaciones , Ochrobactrum anthropi/aislamiento & purificación , Antibacterianos/farmacología , Bacteriemia/microbiología , Recien Nacido Prematuro , Pruebas de Sensibilidad Microbiana , Ochrobactrum anthropi/clasificación , Ochrobactrum anthropi/efectos de los fármacos , Ochrobactrum anthropi/genéticaRESUMEN
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.